Associations of hormone replacement therapy and oral contraceptives with risk of colorectal cancer defined by clinicopathological factors, beta-catenin alterations, expression of cyclin D1, p53, and microsatellite-instability

BACKGROUND: Postmenopausal hormone therapy (HRT) and oral contraceptive (OC) use have in several studies been reported to be associated with a decreased colorectal cancer (CRC) risk. However, data on the association between HRT and OC and risk of different clinicopathological and molecular subsets o...

Descripción completa

Detalles Bibliográficos
Autores principales: Brändstedt, Jenny, Wangefjord, Sakarias, Nodin, Björn, Eberhard, Jakob, Jirström, Karin, Manjer, Jonas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4041054/
https://www.ncbi.nlm.nih.gov/pubmed/24885829
http://dx.doi.org/10.1186/1471-2407-14-371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4041054/
https://www.ncbi.nlm.nih.gov/pubmed/24885829
http://dx.doi.org/10.1186/1471-2407-14-371

Ejemplares similares